In this current research, we firstly reported that circCRKL, back spliced from the second exon of pre-CRKL, was highly expressed in BMMCs of CML patients and BCR-ABL+ cell lines. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.